Nevro Corp. (NYSE:NVRO) this week promoted president Rami Elghandour to be its new CEO, as chief executive Michael DeMane moves to the executive chairman spot. DeMane, the former COO at Medtronic, will keep an active role in Nevro, which he joined in 2011 after a quickly aborted stint at the head of Lanx. He’s due to […]
The Food & Drug Administration slapped Medela Inc. with a warning letter related to reports that the company’s breast pumps were smoking or catching fire.
The company had received 14 complaints about its Pump in Style Advanced electric breast pump that tell of the device’s motors and transformers failing during use, according to the FDA.
The FDA inspected the McHenry, Ill.-based company’s facility in the Fall of 2010 and found that it was falling short of the agency’s "current good manufacturing practice" requirements for medical devices, the warning letter said.